Physician

James Daniel Jensen, MD

According to 2025 Medicare claims, James Jensen, MD (NPI: 1043503568) practices dermatology in the Denver-Aurora-Centennial, CO market, with the plurality of this provider's patient population coming from Douglas, CO. This provider's primary affiliated billing organization is CLARITY DERMATOLOGY PLLC (NPI: 1427569243; TIN: 822302435) and primary practice location at 80112-5172.

Jensen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 599 traditional Medicare patients, billed 4,914 HCPCS/CPT codes, and received $567,286 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 309 prescription claims across 144 beneficiaries totaling $203,631 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 64 records totaling $180,954. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $74,191 to $567,286. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $89,515 and ending at $203,631. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$284K$567K2016 Medicare payment: $74,191 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $131,622 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $59,516 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $90,372 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $136,063 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $293,394 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $293,515 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $297,201 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $567,286 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016214725$74,191
20172321,095$131,622
2018112617$59,516
20192961,343$90,372
20203801,904$136,063
20218407,515$293,394
20225417,946$293,515
20233913,537$297,201
20245994,914$567,286

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$102K$204K2015 Drug cost: $89,515 (USD; Tot_Drug_Cst)2016 Drug cost: $5,535 (USD; Tot_Drug_Cst)2017 Drug cost: $8,835 (USD; Tot_Drug_Cst)2018 Drug cost: $45,470 (USD; Tot_Drug_Cst)2019 Drug cost: $83,683 (USD; Tot_Drug_Cst)2020 Drug cost: $36,146 (USD; Tot_Drug_Cst)2021 Drug cost: $22,200 (USD; Tot_Drug_Cst)2022 Drug cost: $40,264 (USD; Tot_Drug_Cst)2023 Drug cost: $51,735 (USD; Tot_Drug_Cst)2024 Drug cost: $203,631 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015123365$89,515
2016103160$5,535
201771131$8,835
20185073$45,470
201994183$83,683
2020127269$36,146
2021131291$22,200
2022155309$40,264
2023119241$51,735
2024144309$203,631

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks186231$513
11102Biopsy of related skin growth, first growth125140$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more304375$63
17000Destruction of precancer skin growth, 1 growth210258$40
17003Destruction of precancer skin growth, 2-14 growths173910$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab21420$92,755
Dupixent SyringeDupilumab12336$46,022
FluorouracilFluorouracil22635$1,762
Clobetasol PropionateClobetasol Propionate12470$669
Doxycycline HyclateDoxycycline Hyclate19481$540

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.49$1,162ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.15$179,792Avita Medical Americas, Llc
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James Daniel Jensen, MD?

Tedicare shows public-source Medicare data for James Daniel Jensen, MD (NPI 1043503568), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Daniel Jensen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Daniel Jensen, MD?

James Daniel Jensen, MD is linked to CLARITY DERMATOLOGY PLLC (billing NPI 1427569243) in the available physician profile data.

Does James Daniel Jensen, MD have Open Payments data?

James Daniel Jensen, MD has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.